Access to anti-retroviral drugs, female in Honduras

Honduras: Access to anti-retroviral drugs, female was 76.0% in 2024. ◆ Volatile

Latest (2024)
76.0%
Change on year
up 2.7%
World rank
64th
of 141 countries
All-time high
76.0%
in 2024
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Access to anti-retroviral drugs, female in Honduras, 2000–2024

0204060802000201220242000: 0 %2001: 0 %2002: 1 %2003: 8 %2004: 10 %2005: 14 %2006: 20 %2007: 25 %2008: 29 %2009: 34 %2010: 38 %2011: 43 %2012: 47 %2013: 53 %2014: 55 %2015: 60 %2016: 62 %2017: 65 %2018: 67 %2019: 67 %2020: 67 %2021: 69 %2022: 72 %2023: 74 %2024: 76 %

Source: UNAIDS estimates. Measured in %.

Analysis

Honduras recorded 76.0% for access to anti-retroviral drugs, female in 2024. That is the highest value across all 25 years on record.

The figure is up 2.7% on the previous year and up 38.2% over ten years.

Over the whole period, access to anti-retroviral drugs, female in Honduras peaked at 76.0% in 2024 and was at its lowest, 0.0%, in 2000.

That places Honduras 64th out of 141 countries with data for 2024, putting it in the middle of the range.

The series is highly variable year to year, so single readings are best treated with caution.

Access to anti-retroviral drugs, female in Honduras, year by year

Annual values for Access to anti-retroviral drugs, female (%) in Honduras, 2000 to 2024.
Year % Change
2000 0.0%
2001 0.0%
2002 1.0%
2003 8.0% +700.0%
2004 10.0% +25.0%
2005 14.0% +40.0%
2006 20.0% +42.9%
2007 25.0% +25.0%
2008 29.0% +16.0%
2009 34.0% +17.2%
2010 38.0% +11.8%
2011 43.0% +13.2%
2012 47.0% +9.3%
2013 53.0% +12.8%
2014 55.0% +3.8%
2015 60.0% +9.1%
2016 62.0% +3.3%
2017 65.0% +4.8%
2018 67.0% +3.1%
2019 67.0% +0.0%
2020 67.0% +0.0%
2021 69.0% +3.0%
2022 72.0% +4.3%
2023 74.0% +2.8%
2024 76.0% +2.7%

Averages by decade

DecadeAverage LowestHighest Years
2000s 14.1% 0.0% 34.0% 10
2010s 55.7% 38.0% 67.0% 10
2020s 71.6% 67.0% 76.0% 5

Countries ranked near Honduras

  1. 63 Colombia 77.0% compare
  2. 64 Bahamas 76.0% compare
  3. 64 Oman 76.0% compare
  4. 67 Ecuador 75.0% compare
  5. 67 Guyana 75.0% compare

See the full ranking of 160 places →

More gender data for Honduras

All data for Honduras →

Frequently asked questions

What is access to anti-retroviral drugs, female in Honduras?
Access to anti-retroviral drugs, female in Honduras was 76.0% in 2024, according to UNAIDS estimates.
What is the highest access to anti-retroviral drugs, female recorded in Honduras?
The highest recorded value was 76.0% in 2024.
What is the lowest access to anti-retroviral drugs, female recorded in Honduras?
The lowest recorded value was 0.0% in 2000.
How does Honduras rank for access to anti-retroviral drugs, female?
Honduras ranks 64th out of 141 countries with data for 2024.
Is access to anti-retroviral drugs, female rising or falling in Honduras?
Over the last ten years it is up 38.2%. The long-run trend across the full record is volatile.
Where does this Honduras data come from?
The figures come from UNAIDS estimates, published as part of Access to anti-retroviral drugs, female (%). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Access to anti-retroviral drugs, female in Honduras. Statizoid, drawing on UNAIDS estimates. Retrieved 11 September 2026, from https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/honduras/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://gender.statizoid.com/stat/access-to-anti-retroviral-drugs-female-percent/honduras/">Access to anti-retroviral drugs, female in Honduras</a> — Statizoid

About this data

Indicator
Access to anti-retroviral drugs, female (%)
Unit
%
Source
UNAIDS estimates
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
160 places, 3,925 data points, 2000–2024
Last refreshed

The percentage of adult females living with HIV who are receiving antiretroviral therapy.